3hha Citations

Dipeptidyl nitrile inhibitors of Cathepsin L.

Abstract

A series of potent Cathepsin L inhibitors with good selectivity with respect to other cysteine Cathepsins is described and SAR is discussed with reference to the crystal structure of a protein-ligand complex.

Reviews - 3hha mentioned but not cited (2)

  1. Therapeutic strategies for COVID-19: progress and lessons learned. Li G, Hilgenfeld R, Whitley R, De Clercq E. Nat Rev Drug Discov 22 449-475 (2023)
  2. A Review of Small Molecule Inhibitors and Functional Probes of Human Cathepsin L. Dana D, Pathak SK. Molecules 25 E698 (2020)

Articles - 3hha mentioned but not cited (16)



Reviews citing this publication (7)

  1. Cysteine cathepsins: from structure, function and regulation to new frontiers. Turk V, Stoka V, Vasiljeva O, Renko M, Sun T, Turk B, Turk D. Biochim Biophys Acta 1824 68-88 (2012)
  2. Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors. Siklos M, BenAissa M, Thatcher GR. Acta Pharm Sin B 5 506-519 (2015)
  3. Recent Advances in the Discovery of Deubiquitinating Enzyme Inhibitors. Kemp M. Prog Med Chem 55 149-192 (2016)
  4. Cathepsin S inhibitors: 2004-2010. Lee-Dutra A, Wiener DK, Sun S. Expert Opin Ther Pat 21 311-337 (2011)
  5. Cathepsin L in metastatic bone disease: therapeutic implications. Leto G, Sepporta MV, Crescimanno M, Flandina C, Tumminello FM. Biol Chem 391 655-664 (2010)
  6. Cathepsin K: A Versatile Potential Biomarker and Therapeutic Target for Various Cancers. Qian D, He L, Zhang Q, Li W, Tang D, Wu C, Yang F, Li K, Zhang H. Curr Oncol 29 5963-5987 (2022)
  7. Nitriles: an attractive approach to the development of covalent inhibitors. Bonatto V, Lameiro RF, Rocho FR, Lameira J, Leitão A, Montanari CA. RSC Med Chem 14 201-217 (2023)

Articles citing this publication (12)